{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:59:35Z","timestamp":1792195175134,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.arcmed.2022.12.008","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T01:52:32Z","timestamp":1674870752000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of Acute Myeloid Leukemia-derived Extracellular Vesicles on Bone Marrow Mesenchymal Stromal Cells: Expression of Poor Prognosis Genes"],"prefix":"10.1016","volume":"54","author":[{"given":"Yasaman","family":"Kargar-sichani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohyedin","family":"Barzegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1602-319X","authenticated-orcid":false,"given":"Ali","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Bashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi Allahbakhshian","family":"Farsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2022.12.008_bib0001","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.leu.2401568","article-title":"Treatment of relapsed and refractory acute myelogenous leukemia","volume":"14","author":"Estey","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0002","series-title":"Cancer Stem Cell Resistance to Targeted Therapy","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-030-16624-3_7","article-title":"Targeting leukemia stem cells and the immunological bone marrow microenvironment","author":"Maccalli","year":"2019"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0003","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","article-title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","volume":"32","author":"Kumar","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0004","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0005","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fimmu.2018.00738","article-title":"Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression","volume":"9","author":"Willms","year":"2018","journal-title":"Front immunol"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/physiol.00045.2018","article-title":"Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis","volume":"34","author":"Stahl","year":"2019","journal-title":"Physiol J"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0008","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1002\/jcp.27735","article-title":"Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling","volume":"234","author":"Wang","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12253-018-0536-z","article-title":"The expression of interferon gamma (IFN-\u03b3) and interleukin 6 (IL6) in patients with acute lymphoblastic leukemia (ALL)","volume":"26","author":"Farsani","year":"2020","journal-title":"Pathol Oncol"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0010","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/j.1460-2075.1996.tb00734.x","article-title":"A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells","volume":"15","author":"Nakajima","year":"1996","journal-title":"EMBO"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0011","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/onc.2015.374","article-title":"TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition","volume":"35","author":"Pinato","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0012","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbior.2018.09.003","article-title":"Galectins as regulators of cell survival in the leukemia niche","volume":"71","author":"Ruvolo","year":"2019","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0013","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels","volume":"61","author":"Sanchez-Correa","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","article-title":"Normal and leukemic stem cell niches: insights and therapeutic opportunities","volume":"16","author":"Schepers","year":"2015","journal-title":"Cell stem cell"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0015","doi-asserted-by":"crossref","first-page":"C155","DOI":"10.1152\/ajpcell.00017.2019","article-title":"Stem cells and extracellular vesicles: biological regulators of physiology and disease","volume":"317","author":"Borgovan","year":"2019","journal-title":"Am J Physiol"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100595","article-title":"The emerging role of exosomes in multiple myeloma","volume":"38","author":"Moloudizargari","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-016-0307-4","article-title":"ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression","volume":"13","author":"El-Saghir","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0018","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.leukres.2017.09.014","article-title":"Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo","volume":"62","author":"Bouvy","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0019","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0020","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1002\/jcp.27142","article-title":"Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes","volume":"234","author":"Jafarzadeh","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0021","doi-asserted-by":"crossref","first-page":"e97580","DOI":"10.1371\/journal.pone.0097580","article-title":"Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells","volume":"9","author":"Dutta","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0022","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fonc.2019.01135","article-title":"The Yin and Yang of the bone marrow microenvironment: pros and cons of mesenchymal stromal cells in acute myeloid leukemia","volume":"9","author":"Ciciarello","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0023","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3324\/haematol.2017.186734","article-title":"Transforming growth factor \u03b21-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia","volume":"103","author":"Geyh","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0024","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.stemcr.2017.04.019","article-title":"Detailed characterization of mesenchymal stem\/stromal cells from a large cohort of AML patients demonstrates a definitive link to treatment outcomes","volume":"8","author":"de la Guardia","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/leu.2015.325","article-title":"Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia","volume":"30","author":"Geyh","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0026","article-title":"High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer","volume":"12","author":"Silva","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0027","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","article-title":"Interleukin-6 as a therapeutic target","volume":"21","author":"Rossi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0028","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1073\/pnas.1111138108","article-title":"Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia","volume":"108","author":"Yamamoto-Sugitani","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0029","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","article-title":"Galectin 3 as a guardian of the tumor microenvironment","volume":"1863","author":"Ruvolo","year":"2016","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/leu.2013.371","article-title":"GAS6 expression identifies high-risk adult AML patients: potential implications for therapy","volume":"28","author":"Whitman","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0031","doi-asserted-by":"crossref","first-page":"e2700","DOI":"10.1038\/cddis.2017.113","article-title":"Molecular insights of Gas6\/TAM in cancer development and therapy","volume":"8","author":"Wu","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.arcmed.2022.12.008_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.10","article-title":"Acute myeloid leukaemia","volume":"2","author":"Khwaja","year":"2016","journal-title":"Nat Rev Dis Primers"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922001850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440922001850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:52:39Z","timestamp":1759261959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440922001850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0188440922001850"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.12.008","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Acute Myeloid Leukemia-derived Extracellular Vesicles on Bone Marrow Mesenchymal Stromal Cells: Expression of Poor Prognosis Genes","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS).","name":"copyright","label":"Copyright"}]}}